The Wall Street Journal reports today on the nefarious collusion between the Obama White House and Big Pharma executives in developing policy for ObamaCare -- all at the public's expense. As the vast majority of Americans now want the Supreme Court to overturn most of the president's health care overhaul, recently released emails expose the administration's participation in crony capitalism. "If the trove of emails proves anything," the Journal notes, "it's that the Tea Party isn't angry enough."
Over the last year, the Energy and Commerce Committee has taken Nancy Pelosi's advice to see what's in the Affordable Care Act and how it passed. The White House refused to cooperate beyond printing out old press releases, but a dozen trade groups turned over thousands of emails and other files. A particular focus is the drug lobby, President Obama's most loyal corporate ally in 2009 and 2010.
The business refrain in those days was that if you're not at the table, you're on the menu. But it turns out Big Pharma was also serving as head chef, maître d'hotel and dishwasher. Though some parts of the story have been reported before, the emails make clear that ObamaCare might never have passed without the drug companies. Thank you, Pfizer.
The joint venture was forged in secret in spring 2009 amid an uneasy mix of menace and opportunism. The drug makers worried that health-care reform would revert to the liberal default of price controls and drug re-importation that Mr. Obama campaigned on, but they also understood that a new entitlement could be a windfall as taxpayers bought more of their products. The White House wanted industry financial help and knew that determined business opposition could tank the bill.
What the emails reveal is a blatant quid pro quo deal between drug companies and the Obama administration: Support our health care plan and we'll limit the amount that Congress could seize from your company!
Energy and Commerce Chairman Henry Waxman then announced that he was pocketing PhRMA’s concessions and demanding more, including re-importation. We wrote about the double-cross in a July 16, 2009 editorial called “Big Pharma Gets Played,” noting that Mr. Tauzin’s “corporate clients and their shareholders may soon pay for his attempt to get cozy with ObamaCare.” […]
The White House rode to the rescue. In September Mr. Hall informed Mr. Kindler that deputy White House chief of staff Jim Messina “is working on some very explicit language on importation to kill it in health care reform. This has to stay quiet.”
PhRMA more than repaid the favor, with a $150 million advertising campaign coordinated with the White House political shop. As one of Mr. Hall’s deputies put it earlier in the minutes of a meeting when the deal was being negotiated, “The WH-designated folks . . . would like us to start to define what ‘consensus health care reform’ means, and what it might include. . . . They definitely want us in the game and on the same side.”
In particular, the drug lobby would spend $70 million on two 501(c)(4) front groups called Healthy Economy Now and Americans for Stable Quality Care. In July, Mr. Hall wrote that “Rahm asked for Harry and Louise ads thru third party. We’ve already contacted the agent.”
So PhRma forked out $150 million in pro-ObamaCare advertising dispersed from two political front groups and, in exchange, the Obama White House would put a muzzle on Waxman. Crony capitalism at its finest.
WSJ's Joe Rago has more: